2,367
Views
48
CrossRef citations to date
0
Altmetric
Research Article

In vitro antitumor activities of the lichen compounds olivetoric, physodic and psoromic acid in rat neuron and glioblastoma cells

, , &
Pages 1748-1762 | Received 02 Aug 2015, Accepted 25 Nov 2015, Published online: 24 Dec 2015

Figures & data

Table 1. 1H NMR and 13C NMR spectral data of OLA.

Table 2. 1H NMR and 13C NMR spectral data of PHA.

Table 3. 1H NMR and 13C NMR spectral data of PSA.

Figure 1. The chemical structures of lichen secondary metabolites: (a) olivetoric acid, (b) physodic acid and (c) psoromic acid.

Figure 1. The chemical structures of lichen secondary metabolites: (a) olivetoric acid, (b) physodic acid and (c) psoromic acid.

Figure 2. Viability rate in cells exposed to different lichen secondary metabolites (a) for PRCC cells (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n = 3).

Figure 2. Viability rate in cells exposed to different lichen secondary metabolites (a) for PRCC cells (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n = 3).

Table 4. IC50 values for PRCC cells exposed to different lichen secondary metabolites (mg/L).

Table 5. IC50 values for U87MG cells exposed to different lichen secondary metabolites (mg/L).

Figure 3. LDH release level in cells exposed to different lichen secondary metabolites (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Figure 3. LDH release level in cells exposed to different lichen secondary metabolites (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Figure 4. TAC levels of different lichen secondary metabolites on cells (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Figure 4. TAC levels of different lichen secondary metabolites on cells (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Figure 5. TOS levels of different lichen secondary metabolites on cells (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Figure 5. TOS levels of different lichen secondary metabolites on cells (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Figure 6. 8-OH-dG level in cells exposed to different lichen secondary metabolites (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Figure 6. 8-OH-dG level in cells exposed to different lichen secondary metabolites (a) for PRCC cells and (b) for U87MG cells. Each value is expressed as mean ± standard deviation (n=3). Values followed by different small letters differ significantly at p<0.05.

Table 6. Correlation between different variables for PRCC cells exposed to OLA.

Table 7. Correlation between different variables for U87MG cells exposed to OLA.

Table 8. Correlation between different variables for PRCC cells exposed to PHA.

Table 9. Correlation between different variables for U87MG cells exposed to PHA.

Table 10. Correlation between different variables for PRCC cells exposed to PSA.

Table 11. Correlation between different variables for U87MG cells exposed to PSA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.